LncRNA ANCR Suppresses the Progression of Hepatocellular Carcinoma Through the Inhibition of Wnt/β-Catenin Signaling Pathway [Retraction]
Song X, Xu X, Ren X, Ruan X, Wang Y, Yao TT. Onco Targets Ther. 2020;13:8907–8917 At the authors request, the Editor and Publisher of OncoTargets and Therapy are retracting the published article. The authors found errors in the article, including the duplication of images in Figure 3. Spe...
Main Authors: | Song X, Xu X, Ren X, Ruan X, Wang Y, Yao TT |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-04-01
|
Series: | OncoTargets and Therapy |
Online Access: | https://www.dovepress.com/retraction-lncrna-ancr-suppresses-the-progression-of-hepatocellular-ca-peer-reviewed-fulltext-article-OTT |
Similar Items
-
LncRNA TGFB2-OT1 Promotes Progression and Angiogenesis in Hepatocellular Carcinoma by Dephosphorylating β-Catenin
by: Chen Y, et al.
Published: (2023-03-01) -
LncRNA ASB16-AS1 Promotes Growth and Invasion of Hepatocellular Carcinoma Through Regulating miR-1827/FZD4 Axis and Activating Wnt/β-Catenin Pathway [Retraction]
by: Yao X, et al.
Published: (2022-02-01) -
Downregulation of lncRNA OGFRP1 inhibits hepatocellular carcinoma progression by AKT/mTOR and Wnt/β-catenin signaling pathways
by: Chen W, et al.
Published: (2018-07-01) -
RETRACTED ARTICLE: LncRNA CASC15 promotes tumour progression through SOX4/Wnt/β-catenin signalling pathway in hepatocellular carcinoma
by: Chaoyang Wang, et al.
Published: (2020-01-01) -
Gallic Acid Suppressed Tumorigenesis by an LncRNA MALAT1-Wnt/β-Catenin Axis in Hepatocellular Carcinoma
by: Chuan-jian Shi, et al.
Published: (2021-10-01)